Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pfizer Inc (PFE)

36.68 -0.38 (-1.03%)

04-25 16:00

Open:

36.92

Pre. Close:

37.06

High:

37.04

Low:

36.51

Volume:

26,309,450

Market Cap:

218194M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

37.282 - 37.393

37.393 - 37.516

Low:

36.421 - 36.557

36.557 - 36.71

Close:

36.82 - 37.025

37.025 - 37.255

Technical analysis  (as of: 2018-04-25 4:30:02 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 43.53     One year: 50.84

Support:

Support1: 35.44    Support2: 34.32

Resistance:

Resistance1: 37.26    Resistance2: 43.53

Pivot:

36.22

Moving Averages:

MA(5): 36.70     MA(20): 35.99

MA(100): 36.23     MA(250): 34.96

MACD:

MACD(12,26): 0.24     Signal(12,26,9): 0.11

%K %D:

%K(14,3): 93.00     %D(3): 91.07

RSI:

RSI(14): 62.02

52-Week:

High: 39.43  Low: 31.67  Change(%): 9.5

Average Vol(K):

3-Month: 2483558  10-Days 1837062

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PFE has closed below upper band by 7.5%. Bollinger Bands are 15.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-25T10:53:12-04:00
Biogen: Down Too Far, Too Fast?

2018-04-25T08:00:00-04:00
3 Things In Biotech, April 24: A Good, A Bad, And A Strong Maybe

2018-04-24T14:28:02-04:00
By The Numbers: Healthcare Stocks With Big Cash Distributions

2018-04-24T08:00:00-04:00
Your Daily Pharma Scoop: Roche's Ocrevus, Biogen Data, Biohaven Update

2018-04-24T01:51:14-04:00
Biotech Analysis Central Pharma News: Orexigen's Last Resort, Epizyme's Partial Clinical Hold, Eli Lilly And Incyte's Mixed Advisory Panel Vote

2018-04-23T17:35:03-04:00
Dividend Sensei's Portfolio Update 31: 3 Billionaire Habits That Can Make You Rich

2018-04-23T13:46:26-04:00
Unity Biotechnology Finalizes $85 Million IPO Terms

2018-04-23T13:40:29-04:00
Biotech Forum: The Week Ahead

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

5948.59

Shares Float (M)

5933.94

% Held by Insiders

% Held by Institutions

77.20

Shares Short (K)

98319

Shares Short Prior Month (K)

51410

Stock Financials

EPS

2.650

EPS Est. Current Year

2.560

EPS Est. Next Year

2.760

EPS Est. Next Quarter

0.560

Forward EPS

3.060

Book Value (p.s.)

3.050

PEG Ratio

1.77

Profit Margin

46.73

Operating Margin

28.73

Return on Assets (ttm)

11.6

Return on Equity (ttm)

30.6

Qtrly Rev. Growth

0.6

Gross Profit (p.s.)

6.944

Sales Per Share

EBITDA (p.s.)

3.458

Qtrly Earnings Growth

1483.70

Operating Cash Flow (M)

16470.00

Levered Free Cash Flow (M)

13530.00

atoplab.com

Valuation

P/E

13.98

P/E Growth Ratio

0.01

P/BV

12.15

P/S

25057613824.00

P/CF

13.39

Dividend Yield

0.10

Dividends & Splits

Dividend

3.713

Dividend Pay Date

2018-03-01

Ex-Dividend Date

2018-02-01

Forward Dividend

1.360

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.